These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28831541)

  • 1. Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.
    Phipps C; Yeoh KW; Lee YS; Nagarajan C; Gopalakrishnan S; Ho LP; Hwang WYK; Goh YT; Grigoropoulos NF
    Ann Hematol; 2017 Nov; 96(11):1959-1960. PubMed ID: 28831541
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA plasmablastic large B-cell lymphoma.
    Roncati L; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):105-107. PubMed ID: 29536914
    [No Abstract]   [Full Text] [Related]  

  • 3. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
    Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
    Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fistulizing Epstein-Barr virus-positive plasmablastic lymphoma in an HIV-positive man.
    Rangel J; Novoa R; Morrison C; Frank D; Kovarik C
    Br J Dermatol; 2016 Feb; 174(2):398-401. PubMed ID: 26286218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma.
    Nishi K; Mitani S; Hatanaka K; Imada K
    Ann Hematol; 2017 Jun; 96(6):1057-1058. PubMed ID: 28293711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
    García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R
    Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
    Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
    Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
    Qing X; Enbom E; Qing A; French S; Cai J
    Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Violaceous nodules in an HIV-positive man.
    Scott BL; Dominguez AR; Nguyen KD
    Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
    Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
    Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome.
    Fakhri B; Cashen AF; Duncavage EJ; Watkins MP; Wartman LD; Bartlett NL
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e532-e535. PubMed ID: 31279773
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
    Shwe S; Sharma AA; Lee BA; Smith JE
    Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
    Rhoades R; Gong J; Palmisiano N; Alpdogan O
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30872336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV positive mucocutaneous ulcer with plasmacytic/plasmablastic differentiation and MYC rearrangement: a diagnostic challenge and a mimic of plasmablastic lymphoma.
    Chen BJ; Chiang WF; Chen TS; Kao HJ; Chuang SS
    Pathology; 2019 Oct; 51(6):648-650. PubMed ID: 31472984
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders.
    Borenstein J; Pezzella F; Gatter KC
    Histopathology; 2007 Dec; 51(6):774-7. PubMed ID: 17944927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.